Alert detail
FDA Approval: ELIQUIS (APIXABAN) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA202155Specialty: CardiologyAdded: 6/30/2026Effective: 2012-12-28federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.